CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Rokos Capital Management LLP's Holding History (CIK: 0001666335)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023

Shares 87,500 Value ($000) $4,075 Avg Close $51.65 Range $44.53 - $59.67

Q2 2023

Shares 87,500 Value ($000) $4,898 Avg Close $56.74 Range $43.10 - $72.00

Q1 2023

Shares 87,500 Value ($000) $3,949 Avg Close $48.57 Range $39.88 - $58.50

Q4 2022

Shares 87,500 Value ($000) $3,485 Avg Close $53.05 Range $38.94 - $66.31

Q3 2022

Shares 87,500 Value ($000) $5,868 Avg Close $72.47 Range $60.41 - $86.95

Q2 2022

Shares 87,500 Value ($000) $5,499 Avg Close $58.79 Range $42.51 - $75.42

Q1 2022

Shares 87,500 Value ($000) $5,614 Avg Close $62.79 Range $50.54 - $79.40

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2023	87,500	$4,075	$51.65	$44.53 - $59.67
Q2 2023	87,500	$4,898	$56.74	$43.10 - $72.00
Q1 2023	87,500	$3,949	$48.57	$39.88 - $58.50
Q4 2022	87,500	$3,485	$53.05	$38.94 - $66.31
Q3 2022	87,500	$5,868	$72.47	$60.41 - $86.95
Q2 2022	87,500	$5,499	$58.79	$42.51 - $75.42
Q1 2022	87,500	$5,614	$62.79	$50.54 - $79.40